USA Circulating Tumor Cell Market Professional Research Report 2022-2027, Segmented by Players, Types, End-Users in Major Regions

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • Circulating tumor cells are cancer cells that have detached from the tumor and are found at extremely low levels in the bloodstream. The value of capturing and counting CTCs is evolving as more research data is gathered about the utility of these markers in monitoring disease progression and potentially guiding personalized cancer therapy.

    This report offers an overview of the market trends, drivers, and barriers with respect to the USA Circulating Tumor Cell market. It also provides a detailed overview of the market of different regions across West USA, South USA, Middle West USA, Northeast USA. The report deeply analyzes type and application in the USA Circulating Tumor Cell market. Detailed analysis of key players, along with key growth strategies adopted by Circulating Tumor Cell industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.

    By Player:

    • Biocept Inc

    • Menarini Silicon Biosystems

    • Qiagen NV

    • Precision For Medicine (Formerly ApoCell)

    • Miltenyi Biotec

    By Type:

    • CTC Enrichment

    • CTC Detection

    • CTC Analysis

    By End-User:

    • Breast Cancer

    • Prostate Cancer

    • Colorectal Cancer

    • Other

    By Region:

    • West USA

    • South USA

    • Middle West USA

    • Northeast USA

  • TABLE OF CONTENT

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Circulating Tumor Cell Market

    • 1.3 Market Segment by Type

      • 1.3.1 USA Circulating Tumor Cell Market Size and Growth Rate of CTC Enrichment from 2016 to 2027

      • 1.3.2 USA Circulating Tumor Cell Market Size and Growth Rate of CTC Detection from 2016 to 2027

      • 1.3.3 USA Circulating Tumor Cell Market Size and Growth Rate of CTC Analysis from 2016 to 2027

    • 1.4 Market Segment by Application

      • 1.4.1 USA Circulating Tumor Cell Market Size and Growth Rate of Breast Cancer from 2016 to 2027

      • 1.4.2 USA Circulating Tumor Cell Market Size and Growth Rate of Prostate Cancer from 2016 to 2027

      • 1.4.3 USA Circulating Tumor Cell Market Size and Growth Rate of Colorectal Cancer from 2016 to 2027

      • 1.4.4 USA Circulating Tumor Cell Market Size and Growth Rate of Other from 2016 to 2027

    • 1.5 Market Segment by Regions

      • 1.5.1 West USA Circulating Tumor Cell Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.2 South USA Circulating Tumor Cell Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.3 Middle West USA Circulating Tumor Cell Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.4 Northeast USA Circulating Tumor Cell Consumption Market Size and Growth Rate from 2016 to 2027

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    • 2.3 Coronavirus (COVID-19) Distribution and its Impact on the Industry

    3 Segmentation of Circulating Tumor Cell Market by Types

    • 3.1 Products Development Trends of Different Types

    • 3.2 Products Types of Major Vendors

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Circulating Tumor Cell by Major Types

      • 3.4.1 Market Size and Growth Rate of CTC Enrichment

      • 3.4.2 Market Size and Growth Rate of CTC Detection

      • 3.4.3 Market Size and Growth Rate of CTC Analysis

    4 Segmentation of Circulating Tumor Cell Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Circulating Tumor Cell by Major End-Users

      • 4.4.1 Market Size and Growth Rate of Circulating Tumor Cell in Breast Cancer

      • 4.4.2 Market Size and Growth Rate of Circulating Tumor Cell in Prostate Cancer

      • 4.4.3 Market Size and Growth Rate of Circulating Tumor Cell in Colorectal Cancer

      • 4.4.4 Market Size and Growth Rate of Circulating Tumor Cell in Other

    5 Market Analysis by Regions

    • 5.1 USA Circulating Tumor Cell Production Analysis by Regions

    • 5.2 USA Circulating Tumor Cell Consumption Analysis by Regions

    • 5.3 Coronavirus (COVID-19) Impact on USA Economy

    6 West USA Circulating Tumor Cell Landscape Analysis

    • 6.1 West USA Circulating Tumor Cell Landscape Analysis by Major Types

    • 6.2 West USA Circulating Tumor Cell Landscape Analysis by Major End-Users

    7 South USA Circulating Tumor Cell Landscape Analysis

    • 7.1 South USA Circulating Tumor Cell Landscape Analysis by Major Types

    • 7.2 South USA Circulating Tumor Cell Landscape Analysis by Major End-Users

    8 Middle West USA Circulating Tumor Cell Landscape Analysis

    • 8.1 Middle West USA Circulating Tumor Cell Landscape Analysis by Major Types

    • 8.2 Middle West USA Circulating Tumor Cell Landscape Analysis by Major End-Users

    9 Northeast USA Circulating Tumor Cell Landscape Analysis

    • 9.1 Northeast USA Circulating Tumor Cell Landscape Analysis by Major Types

    • 9.2 Northeast USA Circulating Tumor Cell Landscape Analysis by Major End-Users

    10 Major Players Profiles

      • 10.1 Biocept Inc

        • 10.1.1 Biocept Inc Company Profile and Recent Development

        • 10.1.2 Market Performance

        • 10.1.3 Product and Service Introduction

      • 10.2 Menarini Silicon Biosystems

        • 10.2.1 Menarini Silicon Biosystems Company Profile and Recent Development

        • 10.2.2 Market Performance

        • 10.2.3 Product and Service Introduction

      • 10.3 Qiagen NV

        • 10.3.1 Qiagen NV Company Profile and Recent Development

        • 10.3.2 Market Performance

        • 10.3.3 Product and Service Introduction

      • 10.4 Precision For Medicine (Formerly ApoCell)

        • 10.4.1 Precision For Medicine (Formerly ApoCell) Company Profile and Recent Development

        • 10.4.2 Market Performance

        • 10.4.3 Product and Service Introduction

      • 10.5 Miltenyi Biotec

        • 10.5.1 Miltenyi Biotec Company Profile and Recent Development

        • 10.5.2 Market Performance

        • 10.5.3 Product and Service Introduction

    The List of Tables and Figures

    • Figure Product Picture

    • Figure USA Circulating Tumor Cell Market Size and Growth Rate of CTC Enrichment from 2016 to 2027

    • Figure USA Circulating Tumor Cell Market Size and Growth Rate of CTC Detection from 2016 to 2027

    • Figure USA Circulating Tumor Cell Market Size and Growth Rate of CTC Analysis from 2016 to 2027

    • Figure Market Share by Type in 2016

    • Figure Market Share by Type in 2020

    • Figure Market Share by Type in 2027

    • Figure USA Circulating Tumor Cell Market Size and Growth Rate of Breast Cancer from 2016 to 2027

    • Figure USA Circulating Tumor Cell Market Size and Growth Rate of Prostate Cancer from 2016 to 2027

    • Figure USA Circulating Tumor Cell Market Size and Growth Rate of Colorectal Cancer from 2016 to 2027

    • Figure USA Circulating Tumor Cell Market Size and Growth Rate of Other from 2016 to 2027

    • Figure Market Share by End-User in 2016

    • Figure Market Share by End-User in 2020

    • Figure Market Share by End-User in 2027

    • Figure West USA Circulating Tumor Cell Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure South USA Circulating Tumor Cell Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Middle West USA Circulating Tumor Cell Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Northeast USA Circulating Tumor Cell Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Development Trends and Industry Dynamics of Circulating Tumor Cell Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 3 Players in 2019

    • Figure Market Share of TOP 5 Players in 2019

    • Figure Market Share of TOP 6 Players from 2016 to 2020

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Figure Coronavirus (COVID-19) Distribution Map of USA

    • Table Coronavirus (COVID-19) Impact on the Industry

    • Figure Specifications of Different Types of Circulating Tumor Cell

    • Figure Development Trends of Different Types

    • Table Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Circulating Tumor Cell by Different Types from 2016 to 2027

    • Table Consumption Share of Circulating Tumor Cell by Different Types from 2016 to 2027

    • Figure Market Size and Growth Rate of CTC Enrichment

    • Figure Market Size and Growth Rate of CTC Detection

    • Figure Market Size and Growth Rate of CTC Analysis

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Figure Consumption of Circulating Tumor Cell by Different End-Users from 2016 to 2027

    • Table Consumption Share of Circulating Tumor Cell by Different End-Users from 2016 to 2027

    • Figure Market Size and Growth Rate of Breast Cancer

    • Figure Market Size and Growth Rate of Prostate Cancer

    • Figure Market Size and Growth Rate of Colorectal Cancer

    • Figure Market Size and Growth Rate of Other

    • Table USA Circulating Tumor Cell Production by Regions

    • Table USA Circulating Tumor Cell Production Share by Regions

    • Figure USA Circulating Tumor Cell Production Share by Regions in 2016

    • Figure USA Circulating Tumor Cell Production Share by Regions in 2021

    • Figure USA Circulating Tumor Cell Production Share by Regions in 2027

    • Table USA Circulating Tumor Cell Consumption by Regions

    • Table USA Circulating Tumor Cell Consumption Share by Regions

    • Figure USA Circulating Tumor Cell Consumption Share by Regions in 2016

    • Figure USA Circulating Tumor Cell Consumption Share by Regions in 2021

    • Figure USA Circulating Tumor Cell Consumption Share by Regions in 2027

    • Table West USA Circulating Tumor Cell Consumption by Types from 2016 to 2027

    • Table West USA Circulating Tumor Cell Consumption Share by Types from 2016 to 2027

    • Figure West USA Circulating Tumor Cell Consumption Share by Types in 2016

    • Figure West USA Circulating Tumor Cell Consumption Share by Types in 2021

    • Figure West USA Circulating Tumor Cell Consumption Share by Types in 2027

    • Table West USA Circulating Tumor Cell Consumption by End-Users from 2016 to 2027

    • Table West USA Circulating Tumor Cell Consumption Share by End-Users from 2016 to 2027

    • Figure West USA Circulating Tumor Cell Consumption Share by End-Users in 2016

    • Figure West USA Circulating Tumor Cell Consumption Share by End-Users in 2021

    • Figure West USA Circulating Tumor Cell Consumption Share by End-Users in 2027

    • Table South USA Circulating Tumor Cell Consumption by Types from 2016 to 2027

    • Table South USA Circulating Tumor Cell Consumption Share by Types from 2016 to 2027

    • Figure South USA Circulating Tumor Cell Consumption Share by Types in 2016

    • Figure South USA Circulating Tumor Cell Consumption Share by Types in 2021

    • Figure South USA Circulating Tumor Cell Consumption Share by Types in 2027

    • Table South USA Circulating Tumor Cell Consumption by End-Users from 2016 to 2027

    • Table South USA Circulating Tumor Cell Consumption Share by End-Users from 2016 to 2027

    • Figure South USA Circulating Tumor Cell Consumption Share by End-Users in 2016

    • Figure South USA Circulating Tumor Cell Consumption Share by End-Users in 2021

    • Figure South USA Circulating Tumor Cell Consumption Share by End-Users in 2027

    • Table Middle West USA Circulating Tumor Cell Consumption by Types from 2016 to 2027

    • Table Middle West USA Circulating Tumor Cell Consumption Share by Types from 2016 to 2027

    • Figure Middle West USA Circulating Tumor Cell Consumption Share by Types in 2016

    • Figure Middle West USA Circulating Tumor Cell Consumption Share by Types in 2021

    • Figure Middle West USA Circulating Tumor Cell Consumption Share by Types in 2027

    • Table Middle West USA Circulating Tumor Cell Consumption by End-Users from 2016 to 2027

    • Table Middle West USA Circulating Tumor Cell Consumption Share by End-Users from 2016 to 2027

    • Figure Middle West USA Circulating Tumor Cell Consumption Share by End-Users in 2016

    • Figure Middle West USA Circulating Tumor Cell Consumption Share by End-Users in 2021

    • Figure Middle West USA Circulating Tumor Cell Consumption Share by End-Users in 2027

    • Table Northeast USA Circulating Tumor Cell Consumption by Types from 2016 to 2027

    • Table Northeast USA Circulating Tumor Cell Consumption Share by Types from 2016 to 2027

    • Figure Northeast USA Circulating Tumor Cell Consumption Share by Types in 2016

    • Figure Northeast USA Circulating Tumor Cell Consumption Share by Types in 2021

    • Figure Northeast USA Circulating Tumor Cell Consumption Share by Types in 2027

    • Table Northeast USA Circulating Tumor Cell Consumption by End-Users from 2016 to 2027

    • Table Northeast USA Circulating Tumor Cell Consumption Share by End-Users from 2016 to 2027

    • Figure Northeast USA Circulating Tumor Cell Consumption Share by End-Users in 2016

    • Figure Northeast USA Circulating Tumor Cell Consumption Share by End-Users in 2021

    • Figure Northeast USA Circulating Tumor Cell Consumption Share by End-Users in 2027

    • Table Company Profile and Development Status of Biocept Inc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Biocept Inc

    • Figure Sales and Growth Rate Analysis of Biocept Inc

    • Figure Revenue and Market Share Analysis of Biocept Inc

    • Table Product and Service Introduction of Biocept Inc

    • Table Company Profile and Development Status of Menarini Silicon Biosystems

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Menarini Silicon Biosystems

    • Figure Sales and Growth Rate Analysis of Menarini Silicon Biosystems

    • Figure Revenue and Market Share Analysis of Menarini Silicon Biosystems

    • Table Product and Service Introduction of Menarini Silicon Biosystems

    • Table Company Profile and Development Status of Qiagen NV

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Qiagen NV

    • Figure Sales and Growth Rate Analysis of Qiagen NV

    • Figure Revenue and Market Share Analysis of Qiagen NV

    • Table Product and Service Introduction of Qiagen NV

    • Table Company Profile and Development Status of Precision For Medicine (Formerly ApoCell)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Precision For Medicine (Formerly ApoCell)

    • Figure Sales and Growth Rate Analysis of Precision For Medicine (Formerly ApoCell)

    • Figure Revenue and Market Share Analysis of Precision For Medicine (Formerly ApoCell)

    • Table Product and Service Introduction of Precision For Medicine (Formerly ApoCell)

    • Table Company Profile and Development Status of Miltenyi Biotec

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Miltenyi Biotec

    • Figure Sales and Growth Rate Analysis of Miltenyi Biotec

    • Figure Revenue and Market Share Analysis of Miltenyi Biotec

    • Table Product and Service Introduction of Miltenyi Biotec


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.